All News

Top articles of the week from The American Journal of Pharmacy Benefits.

A look at last week's top stories in the world of pharmacy.

A look at last week's top stories in the world of pharmacy.

Learn about the new products and expanded indications approved by the FDA in September 2017.

Novel discovery could lead to targeted cancer therapies.

Electronic health record adoption is high, but integrated records pose a challenge.

Targeting RNA methylation could treat acute myeloid leukemia.

Judge orders tobacco companies to inform Americans about the harmful and addictive properties of smoking.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

The lack of association of SVR with ribavirin dose reflects the wide variance in plasma levels between individuals with hepatitis C receiving the same weight-based dosage.

Heart transplant patients with hepatitis C often cannot not tolerate interferon-based regimens due to cardiac toxicity and other heart-related problems.

Top news of the week from Specialty Pharmacy Times.

Voretigene neparvovec (Luxturna) treats biallelic RPE65-mediated inherited retinal disease.

Secretary of Labor to consider expanding access to Association Health Plans, which could allow employers to form groups across state lines.

This year, the FDA is on pace to approve about 38 new medications. Here is a look at some new dermatology treatments.

The tablets did not get approval for managing fibromyalgia, however, according to a press release from Pfizer.

The plan calls for sale of insurance across state lines.

Abemaciclib (Verzenio) may not improve overall survival in patients with non-small lung cancer.

Provider communication could sway efficacy of selective serotonin reuptake inhibitors.

Afatinib (Gilotrif) may treat patients with non-small cell lung cancer who have certain mutations.

Officials with the New Jersey Attorney General’s office are calling on veterinarians to help combat the opioid epidemic, announcing stricter guidelines aimed at preventing individuals from abusing prescription medications meant for their pets.

Offering medical and pharmacy benefit management can advance the move towards value-based care.

Drinking coffee may have more profound survival benefits for patients with HIV and hepatitis C than for the general population.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Researchers evaluate potential reasons why HIV some drug combinations are more effective in certain patients.

Merck has entered an agreement to develop KalVista Pharmaceuticals’ investigational DME drug.

Injections of intraocular anti-VEGF medications can cause stress among patients with AMD.

DEA campaign called Operation Pilluted targets illegally diverted prescription medications.